Clinical Study

Late Toxicities after Conventional Radiotherapy for Nasopharyngeal Carcinoma: Incidence and Risk Factors

Table 2

Chemotherapy protocols.

ProtocolDrugDose/dayDayInterval

BECBleomycin12 mgD1 bolusD1 = D28
15 mg/m2D1 to D5 (CP)
Epirubicin70 mg/m2D1 (IV)
Cisplatin100 mg/m2D1 (IV)

PF5 fluorouracil1000 mg/m2D1 to D5 (CP)D1 = D28
Cisplatin100 mg/m2D1 (IV)

FCEpirubicin 80 mg/m2D1 (IV)D1 = D21
Cisplatin100 mg/m2D1 (IV)

FFCEpirubicin70 mg/m2D1 (IV)D1 = D21
5 fluorouracil500 mg/m2D1 to D5 (CP)
Cisplatin100 mg/m2D1 (IV)

Abbreviations: CP: continuous perfusion; IV: intravenous.